—— 要投稿,上万维,轻松学术交流

严正声明

本站非期刊官网,非中介代理,
不向作者收取任何费用!
举报微信:13140028228 冯老师

态度公正、信息求实、投稿自助、使用免费
MOLECULAR THERAPY《分子治疗》
月刊 - 美国
  • MOLECULAR THERAPY《分子治疗》
  • SCIE外文期刊
  • 期发文量31
  • 国人占比23.91%
  • 维普目次
  • 投稿方式--官网投稿
  • 期刊属性

  • 中科分区:1区
    OA期刊:混合
  • 综述期刊:
    TOP期刊:
  • 期均国文:7
    环比增速:80.00%
  • 期刊信息

  • 研究方向:医学-BIOTECHNOLOGY APPLIED MICROBIOLOGY 生物工程与应用微生物;GENETICS HEREDITY 遗传学;MEDICINE, RESEARCH EXPERIMENTAL 医学:研究与实验
  • 国际刊号:ISSN 1525-0016;EISSN1525-0024
  • 期刊语言:英语
    出版地区:美国
  • 投稿网址:https://www.editorialmanager.com/molecular-therapy/
  • 电子邮箱:
  • 期刊官网:https://www.cell.com/molecular-therapy-family/home
  • 作者指南:
  • 出版商网址:http://www.cell.com/cellpress
  • 出版地址:50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, USA, MA, 02139
  • 期刊简介:MOLECULAR THERAPY《分子治疗》(月刊). Molecular Therapy is the leading journal for research in the areas of gene transfer, vector development and design, stem cell manipulation, development of gene-, peptide-, protein-, oligonucleotide-, and cell-based therapeutics to correct genetic and acquired diseases, vaccine development, pre-clinical target validation, safety/efficacy studies, and clinical trials. Molecular Therapy is dedicated to promoting the sciences in genetics, medicine, and biotechnology. Publishing important peer-reviewed research and cutting-edge reviews and commentaries, the journal continues to attract the best material in the field.

  • 万维提示






  • 1、投稿方式:在线投稿。

    2、期刊网址:

    https://www.cell.com/molecular-therapy-family/home

    3、投稿网址:

    https://www.editorialmanager.com/molecular-therapy/

    4、官网邮箱:如下。

    5、期刊刊期:月刊,一年出版十二期。

    2021522日星期六

                                 

     

    期刊邮箱【官网信息】

     

    Molecular Therapy

    Editor-in-Chief

    Roland W. Herzog, PhD

    Professor of Pediatrics

    Riley Children’s Foundation Professor of Immunology

    Director, Gene and Cell Therapy Program

    Herman B Wells Center for Pediatric Research

    Indiana University

    Indianapolis, IN 46202

    Email: rwherzog@iu.edu

     

    Executive Editor

    Robert M Frederickson, PhD

    Molecular Therapy Editorial Office

    710 Summit Avenue East

    Seattle, WA 98102

    Tel: +1 323-989-7070

    Email: editor@molther.org

     

    Editorial Office

    Editorial Questions: editor@molther.org

    Technical Questions: journals@asgct.org

     

    投稿须知【官网信息】

     

    Molecular Therapy

    Information for Authors

    This page describes our policies and provides information that we think will be helpful to you as you prepare manuscripts for submission and publication. If you have submitted a paper and want information about the status of the paper, please log in to our online manuscript submission system. If you run into any problems or if you have specific questions, you can always email us at editor@molther.org.

    Editorial Evaluation Timeline

    We read and evaluate every submission, and we try our best to get back to you quickly. We are mindful of how long it can take to publish a paper, so we work with authors and reviewers to minimize that time. Here’s how long each step in the process usually takes:

    Initial decision to review 3–5 days after submission

    Time to first decision 3–4 weeks after submission

    Time suggested for revision 2–3 months

    Time to online publication of accepted manuscript*

    3–5 days after acceptance

    Time to online publication of final proofed manuscript

    3–5 weeks from acceptance

    Time to print publication Within 3 months of acceptance

    *This time applies to OA articles only, not subscription.

    Pre-submission Inquiries

    Unsure if your paper is suitable for Molecular Therapy? Send us a pre-submission inquiry at editor@molther.org, and we’ll let you know in 2–5 days what we think. Please include a title, an abstract, and an explanation of why your paper is significant and broadly interesting.

    Relationship between Molecular Therapy

    Journals

    Co-submission

    If you think your paper might be suitable for two Molecular Therapy journals, you can submit the paper for joint consideration. To do this, upload your manuscript to one of the journals. In your cover letter, please indicate that you are seeking co-consideration and mention the name of the other journal.

    Transfer of Papers between Molecular Therapy Journals

    Although each Molecular Therapy journal is editorially independent, we have a system that allows you to transfer your manuscript, along with the reviews and the reviewers’ identities, from one journal to another. If you have questions about the suitability of your paper for transfer, please contact the editor of the receiving journal. Often, the Editor of the receiving journal will be able to reach a decision based on the existing reviews. Occasionally, the Editor may seek comments from additional reviewers. If you use our online system to transfer your paper, you will have a chance to edit your files before they are sent to the receiving journal. You can always submit your paper to another Molecular Therapy journal without mentioning the first review process. In this case, the manuscript will be evaluated as a regular new submission.

    ……

    更多详情:

    https://marlin-prod.literatumonline.com/pb-assets/journals/society/molecular-therapy/multimedia_files-Authors_MT.pdf







欢迎点评!让信息更透明,使投稿更轻松!
  • 审稿时间:
    是否录用:
  • 见刊周期:
    查重要求:
  • 有无课题:
    有无回复:
  • 我的学历:
    我的职称:
  • 审稿费用:
    版面费用:
  • 稿       费:
    稿件字数:
  • 投稿难度:
  • 该刊可发:
  • 投稿主题:
匿名: 验证码: 点击切换验证码
    评分:0

    验证码: 点击切换验证码